Christopher G. Kanakry

Author

Also Known As

C. G. Kanakry, C.G. Kanakry, Christopher G Kanakry, Christopher G. Kanakry, Christopher George Kanakry, Christopher Kanakry, Jason Reed

162

Publications

Citations

H-Index

Concepts

All Affiliations

National Institutes of Health National Cancer Institute Center for Cancer Research Sidney Kimmel Comprehensive Cancer Center The University of Texas MD Anderson Cancer Center

About

Christopher G. Kanakry is an author at National Institutes of Health specializing in hematology, transplantation, and cell transplantation.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	15	666
2	Blood Transplantation	10	10	468
3	Health Sciences	4	4	103
4	Cell Biology	3	3	171
5	Cellular Therapies	3	3	104

Christopher G. Kanakry

Publications

3.9K

Citations

H-Index

Page 1

	Year	Citations
Aldehyde Dehydrogenase Expression Drives Human Regulatory T Cell Resistance to Posttransplantation Cyclophosphamide Christopher G. Kanakry, Sudipto Ganguly, Marianna Zahurak, Science Translational Medicine	2013	354
Risk-stratified outcomes of nonmyeloablative HLA-haploidentical BMT with high-dose posttransplantation cyclophosphamide Shannon R. McCurdy, Jennifer A. Kanakry, Margaret M. Showel, Blood	2015	297
Multi-Institutional Study of Post-Transplantation Cyclophosphamide As Single-Agent Graft-Versus-Host Disease Prophylaxis After Allogeneic Bone Marrow Transplantation Using Myeloablative Busulfan and Fludarabine Conditioning Christopher G. Kanakry, Paul V. O’Donnell, Terry Furlong, Journal of Clinical Oncology	2014	271
Posttransplantation cyclophosphamide prevents graft-versus-host disease by inducing alloreactive T cell dysfunction and suppression Lucas P. Wachsmuth, Michael T. Patterson, Michael Eckhaus, Journal of Clinical Investigation	2019	271
Single-agent GVHD prophylaxis with posttransplantation cyclophosphamide after myeloablative, HLA-matched BMT for AML, ALL, and MDS Christopher G. Kanakry, Hua-Ling Tsai, Javier Bolaños‐Meade, Blood	2014	196
Donor CD4+ Foxp3+ regulatory T cells are necessary for posttransplantation cyclophosphamide-mediated protection against GVHD in mice Sudipto Ganguly, Duncan B. Ross, Angela Panoskaltsis‐Mortari, Blood	2014	193
Comparable composite endpoints after HLA-matched and HLA-haploidentical transplantation with post-transplantation cyclophosphamide Shannon R. McCurdy, Yvette L. Kasamon, Christopher G. Kanakry, Haematologica ImmunologySurgeryImmunotherapyTranslational MedicineBone Marrow Failure	2016	186
Posttransplant cyclophosphamide is associated with increased cytomegalovirus infection: a CIBMTR analysis Scott Goldsmith, Muhammad Bilal Abid, Jeffery J. Auletta, Blood	2021	168
HLA-haploidentical vs matched unrelated donor transplants with posttransplant cyclophosphamide-based prophylaxis Mahasweta Gooptu, Rizwan Romee, Andrew St. Martin, Blood	2021	157
Origin and evolution of the T cell repertoire after posttransplantation cyclophosphamide Christopher G. Kanakry, David G. Coffey, Andrea Towlerton, JCI Insight	2016	142

Page 1